[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

LV10688A - Pretalergisks sastavs oftalmologijai vai deguna slimibam - Google Patents

Pretalergisks sastavs oftalmologijai vai deguna slimibam

Info

Publication number
LV10688A
LV10688A LV931369A LV931369A LV10688A LV 10688 A LV10688 A LV 10688A LV 931369 A LV931369 A LV 931369A LV 931369 A LV931369 A LV 931369A LV 10688 A LV10688 A LV 10688A
Authority
LV
Latvia
Prior art keywords
ophthalmology
allergic composition
nasal disease
composition
nasal
Prior art date
Application number
LV931369A
Other languages
English (en)
Other versions
LV10688B (en
Inventor
Yoshifumi Ikejiri
Takahiro Ogawa
Fuminori Tokumochi
Shogo Sameshima
Motoko Kimura
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of LV10688A publication Critical patent/LV10688A/lv
Publication of LV10688B publication Critical patent/LV10688B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/724Cyclodextrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/81Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LVP-93-1369A 1992-12-25 1993-12-24 Antiallergic composition for ophthalmic or nasal use LV10688B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34603192 1992-12-25

Publications (2)

Publication Number Publication Date
LV10688A true LV10688A (lv) 1995-06-20
LV10688B LV10688B (en) 1995-10-20

Family

ID=18380671

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-1369A LV10688B (en) 1992-12-25 1993-12-24 Antiallergic composition for ophthalmic or nasal use

Country Status (23)

Country Link
US (1) US5419898A (lv)
EP (1) EP0605203B1 (lv)
JP (1) JP3683595B2 (lv)
KR (1) KR100276743B1 (lv)
CN (1) CN1050514C (lv)
AT (1) ATE164068T1 (lv)
AU (1) AU666413B2 (lv)
BG (1) BG61101B1 (lv)
CA (1) CA2112014C (lv)
CZ (1) CZ283029B6 (lv)
DE (1) DE69317537T2 (lv)
DK (1) DK0605203T3 (lv)
ES (1) ES2115733T3 (lv)
FI (1) FI111805B (lv)
HU (2) HU218672B (lv)
LT (1) LT3344B (lv)
LV (1) LV10688B (lv)
NO (2) NO304176B1 (lv)
NZ (1) NZ250519A (lv)
PL (1) PL173347B1 (lv)
RU (1) RU2130774C1 (lv)
SK (1) SK279503B6 (lv)
TW (1) TW401300B (lv)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897858A (en) 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
EP0780127A1 (en) * 1995-12-19 1997-06-25 The Procter & Gamble Company A nasal spray containing a steroid and a antihistamine
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
CA2266898A1 (en) * 1996-09-27 1998-04-02 Nastech Pharmaceutical Co., Inc. Intranasal formulations for promoting sleep and method of using the same
BE1011251A3 (fr) * 1997-07-03 1999-06-01 Ucb Sa Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
EP0919550A1 (en) 1997-11-26 1999-06-02 Ucb, S.A. Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
AU757896B2 (en) 1998-09-02 2003-03-13 Allergan, Inc. Preserved cyclodextrin-containing compositions
BR9804993A (pt) * 1998-11-10 2000-06-06 Panacea Biotec Ltd Composição antialérgica e antiinflamatória
JP2001125052A (ja) * 1999-10-25 2001-05-11 Lion Corp コンタクトレンズ装着液
US6258814B1 (en) * 2000-10-13 2001-07-10 Schering Corporation Method of using cetirizine and pharmaceutical compositions containing the same for inducing sleep
KR101005648B1 (ko) * 2002-01-15 2011-01-05 유씨비 파쉼 소시에떼아노님 제형
JP4543274B2 (ja) * 2002-10-01 2010-09-15 大正製薬株式会社 点鼻剤組成物
US6933289B2 (en) 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20050255154A1 (en) * 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
WO2005115345A1 (en) * 2004-05-28 2005-12-08 Imaginot Pty Ltd Oral therapeutic compound delivery system
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
JP2006008568A (ja) * 2004-06-24 2006-01-12 Cyclochem:Kk IgE抗体抑制剤および食品
PE20060484A1 (es) * 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
DE602005020796D1 (de) * 2004-07-22 2010-06-02 Bend Res Inc Geschmacksabdeckende formulierung mit einer retardierten wirkstoffformulierung und/oder schnell löslichem cyclodextrin
EP1888548B1 (en) 2005-05-26 2012-08-22 Neuron Systems, Inc Quinoline derivative for the treatment of retinal diseases
WO2006137433A1 (ja) * 2005-06-21 2006-12-28 Wakamoto Pharmaceutical Co., Ltd. レボカバスチンを可溶化させた水性薬剤
EP3263117A1 (en) * 2005-11-28 2018-01-03 Imaginot Pty Ltd. Oral therapeutic compound delivery system
EP1994933B1 (en) * 2006-03-13 2017-04-26 R-Tech Ueno, Ltd. Aqueous composition
WO2008025560A1 (en) * 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
CN101284026B (zh) * 2007-04-12 2010-11-10 鲁南制药集团股份有限公司 一种用于治疗皮肤过敏性疾病的药物组合物
US9358242B2 (en) * 2007-08-30 2016-06-07 Prelief Inc. Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
JP6033677B2 (ja) * 2009-03-17 2016-11-30 ナイコックス オフサルミクス, インコーポレイテッド セチリジンの眼科用製剤および使用方法
US8569273B2 (en) * 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8263581B2 (en) * 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
JP2013501735A (ja) * 2009-08-12 2013-01-17 ルナン ベター ファーマシューティカル カンパニー リミテッド セチリジン塩酸塩の薬剤溶液
JP5702795B2 (ja) 2009-11-06 2015-04-15 イェール ユニバーシティーYale University 両親媒性化合物ならびにその調製および使用方法
WO2011072141A1 (en) 2009-12-11 2011-06-16 Neuron Systems, Inc. Compositions and methods for the treatment of macular degeneration
ES2784629T3 (es) * 2011-11-29 2020-09-29 Jurox Pty Ltd Composiciones farmacéuticas inyectables estables que comprenden 2-hidroxipropil-beta-ciclodextrina y alfaxalona
CN111135171B (zh) 2013-01-23 2023-09-08 奥尔德拉医疗公司 与毒性醛相关的疾病和治疗
EP3337486B1 (en) 2015-08-21 2024-04-03 Aldeyra Therapeutics, Inc. Deuterated compounds and uses thereof
WO2017147617A1 (en) 2016-02-28 2017-08-31 Aldeyra Therapeutics, Inc. Treatment of allergic eye conditions with cyclodextrins
MX2018013472A (es) 2016-05-09 2019-02-28 Aldeyra Therapeutics Inc Tratamiento de combinacion de trastornos y enfermedades inflamatorios oculares.
US11241426B2 (en) * 2017-02-13 2022-02-08 Nitto Medic Co., Ltd. Aqueous composition for ophthalmic or nasal administration
EP3596040B1 (en) 2017-03-16 2023-10-11 Aldeyra Therapeutics, Inc. Polymorphic salt of 6-chloro-3-amino-2(2-hydroxypropyl)quinoline and uses thereof
JP7311162B2 (ja) 2017-10-10 2023-07-19 アルデイラ セラピューティクス, インコーポレイテッド 炎症性障害の処置
PT3740191T (pt) 2018-01-18 2021-07-09 Faes Farma Sa Composições oftálmicas compreendendo bilastina, uma beta-ciclodextrina e pelo menos um agente gelificante
EP3833660A4 (en) 2018-08-06 2022-05-11 Aldeyra Therapeutics, Inc. POLYMORPHIC COMPOUNDS AND THEIR USES
EP3856478A4 (en) 2018-09-25 2022-06-08 Aldeyra Therapeutics, Inc. FORMULATIONS FOR THE TREATMENT OF DRY EYE DISEASE
JP2022526917A (ja) 2019-03-26 2022-05-27 アルデイラ セラピューティクス, インコーポレイテッド 眼科用製剤およびその使用
EP3725298A1 (en) * 2019-04-16 2020-10-21 Faes Farma, S.A. Stable and preserved pharmaceutical compositions of bilastine
WO2020223717A1 (en) 2019-05-02 2020-11-05 Aldeyra Therapeutics, Inc. Process for preparation of aldehyde scavenger and intermediates
CA3137301A1 (en) 2019-05-02 2020-11-05 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
EP4149470A4 (en) 2020-05-13 2024-04-24 Aldeyra Therapeutics, Inc. PHARMACEUTICAL FORMULATIONS AND USES THEREOF

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75816C (fi) * 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5192780A (en) * 1989-12-18 1993-03-09 Alcon Laboratories, Inc. Methods using antiallergics and antihistamines
AU636685B2 (en) * 1989-12-18 1993-05-06 Alcon Laboratories, Inc. Compositions of antiallergics and antihistamines and methods for their use
IT1246188B (it) * 1990-07-27 1994-11-16 Resa Farma Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
JPH06311353A (ja) 1993-04-19 1994-11-04 Brother Ind Ltd カラー画像形成装置
JP2619828B2 (ja) 1996-06-17 1997-06-11 九州日立マクセル株式会社 電動式爪みがき機

Also Published As

Publication number Publication date
HU9303746D0 (en) 1994-04-28
NO934630D0 (no) 1993-12-15
LTIP1669A (en) 1994-10-25
SK279503B6 (sk) 1998-12-02
DE69317537T2 (de) 1998-07-09
FI935851A0 (fi) 1993-12-23
SK147493A3 (en) 1994-07-06
PL301588A1 (en) 1994-06-27
EP0605203A2 (en) 1994-07-06
KR100276743B1 (ko) 2001-01-15
ES2115733T3 (es) 1998-07-01
BG61101B1 (bg) 1996-11-29
CN1094614A (zh) 1994-11-09
HU211972A9 (en) 1996-01-29
HU218672B (hu) 2000-10-28
KR940013511A (ko) 1994-07-15
CZ283693A3 (en) 1994-07-13
FI111805B (fi) 2003-09-30
JPH06239748A (ja) 1994-08-30
CA2112014A1 (en) 1994-06-26
TW401300B (en) 2000-08-11
US5419898A (en) 1995-05-30
ATE164068T1 (de) 1998-04-15
FI935851A (fi) 1994-06-26
EP0605203A3 (en) 1994-11-02
AU666413B2 (en) 1996-02-08
NZ250519A (en) 1995-03-28
BG98327A (bg) 1994-08-30
CA2112014C (en) 2004-11-02
DE69317537D1 (de) 1998-04-23
DK0605203T3 (da) 1998-12-07
AU5259793A (en) 1994-07-07
EP0605203B1 (en) 1998-03-18
CN1050514C (zh) 2000-03-22
LT3344B (en) 1995-07-25
HUT69385A (en) 1995-09-28
PL173347B1 (pl) 1998-02-27
CZ283029B6 (cs) 1997-12-17
LV10688B (en) 1995-10-20
RU2130774C1 (ru) 1999-05-27
NO304176B1 (no) 1998-11-09
NO934630L (no) 1994-06-27
JP3683595B2 (ja) 2005-08-17

Similar Documents

Publication Publication Date Title
LV10688A (lv) Pretalergisks sastavs oftalmologijai vai deguna slimibam
RU93056633A (ru) Антиаллергическая композиция для лечения глаз или носа
ATE121295T1 (de) Augentropfenarzneimittel.
ES2058892T3 (es) Uso de omeprazol como agente antimicrobiano.
DE59108530D1 (de) Antimikrobielle Mittel sowie substituierte 2-Cyclohexan-1-yl-amin-Derivate und deren Herstellung
EP0990648A4 (en) DERIVATIVES OF 4-CHINOLOL AND AGRICULTURAL AND GARDENING BACTERICIDES THAT CONTAIN THEM AS AN ACTIVE COMPONENT
DE69525354D1 (de) Eine neuartige medizinische verwendung eines 5ht 3-antagonisten
CA2234247A1 (en) An agent for curing ophthalmological diseases
BR9913699A (pt) Composição inseticida
IT8919737A0 (it) Impiego di 5' metiltioadenosina, s adenosilmetionina e dei loro sali per la preparazione di composizioni farmaceutiche atte a ridurre la seborrea e composizioni farmaceutiche relative.
DE69106777D1 (de) Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination.
NO901631D0 (no) Fremgangsmaate for fremstilling av 2-substituerte n,n'-ditrimetoksybenzoyl-piperaziner.
IT1197081B (it) Composizione sterilizzante ad attivita' antibatterica e antimicetica a base di glutaraldede, in veicolo acquoso
DE59000613D1 (de) Pflaster zur transdermalen anwendung.
CA2349452A1 (en) Therapeutic agents for drug dependence
BR0102138B1 (pt) formulaÇço oftÁlmica aquosa para o tratamento e prevenÇço de infecÇÕes, e, uso de um quitosano.
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
EP0509098A4 (en) Ataractic
FI930358A0 (fi) Vattenhaltiga polymeratpreparat
ES1014676Y (es) Instrumento para capsulotomia ocular anterior.
IT9007001A0 (it) Presidio per incontinenza urinaria maschile "sacro cuore".